Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.12%, DAX +0.13%, CAC +0.08%

Aug 28 ,2025

  • Synopsis

    • European equity markets are set to open in positive territory amid Asian equities mixed Thursday. Hang Seng weighed down service delivery providers following Meituan's earnings. Mild gains in Japan and Korea while Taiwan and Australia little changed. Nasdaq futures weighed down by NVDA following earnings. Treasuries flat while JGB curve bull flattening. Dollar touch softer against yen, weakest against Korean won following BOK hold. Crude pulling back from earlier highs while gold flat. Bitcoin hovering near early July lows.

    • In political developments focus is on France, where French Prime Minister François Bayrou warned on Wednesday that his government's likely collapse next month would drag France into a dangerous abyss (Politico). France's parliament will convene for an extraordinary session in less than two weeks, with MPs set to vote on the viability of Prime Minister François Bayrou's government and his package of austerity measures aiming to cut France's spiralling deficit. The suggested budget cuts have already proved unpopular among politicians on the left and right, and with the general public (France24 ).

    • In central banks, Bank of Finland's Rehn will deliver at 10:00CET the 2025 Esko Antola Lecture (followed by discussion) at Europe Forum, theme 'A Strong Europe in a World of Confrontation'. ECB minutes of last MPC meeting released at 13:30CET. Poland central bank releases minutes of last MPC meeting. In politics, EU defence ministers will gather in Copenhagen (through Fri). Pre-event to discuss a defence industry cooperation with Ukraine, and Nordic defence cooperation.

    • Macroeconomic data includes: Italy Aug business/consumer confidence, Switzerland Q2 final GDP, Eurozone Aug economic/service sentiment, Jul M3 money supply, Sweden Jul trade balance, Belgium Aug CPI, Ireland Jul Retail sales. Also, European Automobile Manufacturers' Association (ACEA) July new passenger car registrations for EU + EFTA + UK.

    • In corporate news, Delivery Hero (DHER.GR) posted H1 earnings this morning. The company also updated its FY25 guidance yesterday after the close to reflect foreign exchange rate headwinds, now expecting lower adjusted EBITDA and FCF. Still in the DACH region, Fielmann Group (FIE.GR) released final H1 numbers. SoftwareONE Holding (SWON.SW) reported H1 earnings in line with preliminary. STRABAG (STR.AV) is also out with H1 earnings and confirmed FY guidance. In France, Eiffage (FGR.FP) reported yesterday after the close H1 net income €308M vs FactSet €304.7M and confirmed outlook. Also today before the open, Pernod Ricard (RI.FP) released FY earnings. Out of the Nordics, Elekta (EKTA.B.SS) and Elon AB (ELON.SS) updated the market with their most recent earnings. Per Aarsleff Holding (PAAL.B.DC) posted Q3 earnings and narrowed its FY guidance.

  • Macro/politics

    • Netherland's PM Schoof survived a no-confidence vote - Bloomberg

    • France, Germany and UK prepare to reimpose sanctions on Iran - FT

    • Denmark summons US envoy over suspected influence operations in Greenland - Reuters

  • Top company news

    • Earnings/updates

      • DACHs

        • DHER.GR (Delivery Hero) -- reports H1 adjusted EBITDA €410.7M vs consensus €384M

          • updates FY25 guidance to reflect foreign exchange rate headwinds, now expecting lower adjusted EBITDA and FCF

        • SWON.SW (SoftwareONE Holding) -- reports H1 EPS CHF0.19 vs FactSet CHF0.22 [1 est]

        • CAI.AV (CA Immobilien Anlagen) -- reports H1 FFO I €62.9M vs year-ago €55.0M

        • STR.AV (STRABAG SE) -- reports H1 EPS €0.82 vs year-ago €0.84

        • ED4.GR (EDAG Engineering Group) -- confirms preliminary H1 numbers as of 11-Aug

        • PKTM.SW (PIERER Mobility) -- reports H1 net income €739M vs year-ago (€172M) and preliminary €740M

        • FIE.GR (Fielmann Group) -- reports H1 EPS €1.23 vs year-ago €1.01; revenues and adj. EBITDA in line with 10-Jul prelims

      • Benelux

        • CMBT.BB (CMB.TECH) -- reports Q2 net income attributable $7.8M vs FactSet $20.8M [3 est, $7.8-40.7M]

        • IBAB.BB (Ion Beam Applications) -- reports H1 net income (€2.6M) vs year-ago (€10.3M); reaffirms FY guidance and mid-term outlook

      • France

        • FGR.FP (Eiffage) -- reports H1 net income €308M vs FactSet €304.7M [3 est, €291-314M]

        • IDL.FP (ID Logistics Group) -- reports H1 net income €23.3M vs year-ago €18.0M

        • GDS.FP (Ramsay Générale de Santé) -- reports FY net income (€54.1M) vs year-ago (€53.9M)

        • RI.FP (Pernod Ricard) -- reports FY revenue €10.96B vs FactSet €10.95B [16 est, €10.82-11.19B]

      • Nordic

        • EKTA.B.SS (Elekta) -- reports Q1 Adj. EPS SEK0.31 vs consensus SEK0.28

        • ELON.SS (Elon AB) -- reports Q2 EPS (SEK1.81) vs year-ago SEK0.40

        • PAAL.B.DC (Per Aarsleff Holding) -- reports Q3 EPS DKK12.37 vs FactSet DKK8.86 [3 est, DKK0.00-13.48]; narrows FY guidance

    • M&A

      • CON.GR (Continental) -- agrees to sell its ContiTech business area Original Equipment Solutions to Regent for an undisclosed sym

      • BNR.GR (Brenntag) -- believes chemical industry needs consolidation to remain competitive - FAZ

      • SXS.LN (Spectris) -- Bidco intends to appoint Andrew Williams as Chairman of board of Spectris and Pat Murphy as Vice Chairman of board of Spectris upon scheme becoming effective

      • EXENS.FP (Exosens) -- announces agreement to acquire Phasics

      • WHR.LN (Warehouse REIT) -- BBOX has confirmed to Warehouse REIT that it no longer wishes to proceed with BBOX offer

      • JUVE.IM (Juventus Football Club) -- Juventus Football Club agrees to sell the player Djalo to Besiktas for €3.5M plus addition variable bonuses up to €1M

    • Healthcare

      • SDZ.SW (Sandoz Group) -- announces launch of generic rivaroxaban in Germany

      • ALBPS.FP (Biophytis) -- Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial

      • HPHA.GR (Heidelberg Pharma) -- notes Telix's receiving CRL from FDA for TLX250-CDx

      • BIOG.B.SS (BioGaia) -- BioGaia's newly elected chairman agrees to purchase 735,754 class B shares from Anatom Holding, BioGaia's anchor shareholder

      • ATORX.SS (Alligator Bioscience) -- announces subscription price for warrants series TO 13 set at SEK 3.12

    • Other

      • SUBC.NO (Subsea 7) -- awarded contract by Turkish Petroleum Offshore Technology Center for the development of phase 3 of the Sakarya field development in the Black Sea

      • SMWH.LN (WH Smith) -- board backs CEO Carl Cowling as it awaits outcome of investigation into profit overstatement - FT

  • Key rating changes

    • Upgrades/downgrades

      • BNP Paribas Exane transfers CURY.LN, SMWH.LN

      • Jefferies upgrades BSL.GR, COK.GR; downgrades ALFEN.NA, DMP.GR, FUR.NA, and VH2.GR

    • Initiations

      • GF.SW (Georg Fischer) -- outperform at Oddo

  • Data

    • Nikkei +0.66% to 42801.97

    • Hang Seng (1.03%) to 24943.20

    • Shanghai Composite (0.20%) to 3792.60

    • S&P futures (7.5) vs prior close of 6496

    • €-$ +0.0000 or +0.00% to 1.1641

    • $-¥ (0.30) or (0.20%) to 147.10

    • €-¥ (0.37) or (0.22%) to 171.18

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE